William Blair & Company
ARIA

William Blair & Company’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

William Blair & Company’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-43,685
Closed -$236K – 2188
2014
Q3 		$236K Buy
43,685
+24,980
+134% +$146K ﹤0.01% 1919
2014
Q2 		$118K Buy
+18,705
New +$129K ﹤0.01% 1995
2014
Q1 		– Sell
-13,030
Closed -$89K – 2089
2013
Q4 		$89K Sell
13,030
-14,412
-53% -$77.8K ﹤0.01% 1923
2013
Q3 		$505K Buy
27,442
+17,112
+166% +$332K ﹤0.01% 1551
2013
Q2 		$180K Buy
+10,330
New +$183K ﹤0.01% 1824

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair & Company's ARIA Position: Q4 2014 in Review

William Blair & Company sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2014, closing a stake of 43,685 shares — an estimated $236K sold.

William Blair & Company first reported a position in ARIA in Q2 2013 and held it in 5 quarters. The position peaked at $505K in Q3 2013. 179 funds tracked by Wall St. Rank hold ARIA as of Q4 2014.

  • William Blair & Company reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • William Blair & Company sold 43,685 Ariad Pharmaceuticals Inc shares in Q4 2014, an estimated $236K.
  • William Blair & Company first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • William Blair & Company's Ariad Pharmaceuticals Inc position peaked at $505K in Q3 2013.
  • 179 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2014.

Based on William Blair & Company's 13F filing for Q4 2014, filed 5 Feb 2015.